Join a Medical Study on Metformin and Aging!
October 8, 2025
In our March 19 post, we highlighted a study exploring the potential of metformin to slow aging. Now, the landmark TAME (Targeting Aging with Metformin) Trial is recruiting adults aged 65–79 to help test whether this trusted diabetes drug can delay or prevent chronic diseases like heart disease, cancer, and dementia. Spanning 14 leading research centers over six years, this is your chance to help redefine how we approach aging itself. Learn more and sign up for updates here.